Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers

开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验

基本信息

  • 批准号:
    10427936
  • 负责人:
  • 金额:
    $ 18.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-15 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

(K.220) 7. Project Summary/Abstract Opioid use disorder (OUD) is associated with disproportionate deficits in the psychosocial determinants of health, with individuals exhibiting recovery capital (i.e. recovery resources) that is one standard deviation below that of other substance use disorders (SUDs) in the first year of recovery. OUD medications (MOUDs) are first-line treatments (Txs) that facilitate recovery by addressing the biophysiological disturbances caused by chronic opioid misuse. Yet, high rates of MOUD discontinuation and associated risks are ongoing concerns and, even when patients (Ps) are retained in Tx, psychosocial deficits often persist, increasing biobehavioral stress and hindering Tx/recovery. Thus, without a foundation of resources for recovery support/maintenance, current and former MOUD Ps are at ongoing risk for psychosocial impairment, which hinders recovery. The provision of recovery support services (RSS) offers one way to address extra-Tx needs and enhance recovery capital to ensure a safety net of resources and healthy coping skills to support MOUD Ps during and after Tx. Recovery Community Centers (RCCs) are a free, newly emerging, and rapidly growing tier of RSS that serve as ‘one-stop- shops’ for recovery capital, offering an array of services catered to the SUD community. RCCs seem to be especially well suited for MOUD Ps, as they operate under the maxim “many pathways [to recovery], all should be celebrated” (including MOUD), and the majority of RCC attendees have OUD and hold positive attitudes toward MOUD. Though early evidence suggests that RCCs can aid SUD recovery, its potential benefit to MOUD Ps has yet to be directly studied. Also, few MOUD Ps know of or use RCCs, and clinical linkage to them is uncommon. Thus, this 5-year project seek to advance our understanding of the clinical and public health utility of RCCs and help bridge the gap between clinical Tx and community-based RSS. As a first step in this work, we will develop and test a new intervention for peer-facilitated assertive linkage of MOUD Ps to RCCs (RCCL), relative to a matched control condition (CC). This study aims to: (1) develop, manualize, and refine RCCL/CC protocols via stakeholder feedback; (2) determine feasibility, acceptability, and preliminary efficacy (RCC attendance, service use, recovery capital) of RCCL vs. CC, via a pilot randomized controlled trial (RCT); (3) Gain in-depth insight to RCCL via qualitative interviews. This study will be the first to test RCCL for MOUD Ps, providing a foundation for larger-scale RCTs, with the potential to ultimately change clinical practice paradigms to address Ps’ extra-Tx needs and inform our ability to expand RCCL provision nationally. The aims support advanced training in: psychosocial determinants of health; RSS; intervention development/testing (via RCT); qualitative methods; ongoing OUD training, with a new focus on intervention research. Training will be fulfilled with expert guidance from Drs. John Kelly, Roger Weiss, Joanne Neale, David Best, Christine Timko, and Corrie Vilsaint. The training and experience provided by this award will serve as a critical foundation from which to build a an important and clinically relevant program of independent research.
(K.220) 7. 项目总结/摘要 阿片类药物使用障碍(OUD)与健康的心理社会决定因素的不成比例的缺陷有关, 个人表现出的回收资本(即回收资源)比以下一个标准差 康复第一年的其他物质使用障碍 (SUD)。 OUD 药物 (MOUD) 是一线药物 通过解决慢性病引起的生物生理紊乱来促进康复的治疗(Txs) 阿片类药物滥用。然而,MOUD 的高终止率和相关风险一直令人担忧,甚至 当患者 (Ps) 留在 Tx 中时,心理社会缺陷通常会持续存在,从而增加生物行为压力和 阻碍 Tx/恢复。因此,如果没有恢复支持/维护的资源基础,当前和 前 MOUD P 持续面临社会心理障碍的风险,这阻碍了康复。提供 恢复支持服务 (RSS) 提供了一种解决额外 Tx 需求并增强恢复资本的方法 确保资源安全网和健康的应对技能,以在 Tx 期间和之后支持 MOUD P。恢复 社区中心 (RCC) 是一种免费、新兴且快速增长的 RSS 层级,可提供“一站式服务” 商店的回收资本,提供一系列迎合 SUD 社区的服务。农村信用社似乎 特别适合 MOUD P,因为它们遵循“许多途径(恢复),都应该 值得庆祝”(包括 MOUD),大多数 RCC 与会者都有 OUD 并持有积极态度 走向MOUD。尽管早期证据表明 RCC 可以帮助 SUD 复苏,但它对 MOUD 的潜在好处 Ps尚未直接研究。此外,很少有 MOUD P 了解或使用 RCC,并且与它们的临床联系是 罕见。因此,这个为期 5 年的项目旨在增进我们对临床和公共卫生效用的理解 的 RCC 并帮助弥合临床 Tx 和基于社区的 RSS 之间的差距。作为这项工作的第一步,我们 将开发和测试一种新的干预措施,用于同行促进的 MOUD P 与 RCC (RCCL) 的肯定联系, 相对于匹配的控制条件(CC)。本研究旨在:(1) 开发、手册化和完善 RCCL/CC 通过利益相关者的反馈制定协议; (2) 确定可行性、可接受性和初步有效性(RCC RCCL 与 CC 的出勤率、服务使用、回收资本),通过试点随机对照试验 (RCT) 进行; (3) 增益 通过定性访谈深入了解 RCCL。这项研究将是第一个针对 MOUD Ps 测试 RCCL 的研究, 为更大规模的随机对照试验提供基础,有可能最终改变临床实践范式 满足 Ps 的额外 Tx 需求,并告知我们在全国范围内扩大 RCCL 供应的能力。目标支持 高级培训:健康的社会心理决定因素; RSS;干预开发/测试(通过随机对照试验); 定性方法;正在进行的 OUD 培训,新的重点是干预研究。培训将圆满完成 在博士的专家指导下。约翰·凯利、罗杰·韦斯、乔安妮·尼尔、大卫·贝斯特、克里斯汀·蒂姆科和科里 维尔圣。该奖项提供的培训和经验将作为构建的重要基础 一项重要且与临床相关的独立研究计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lauren A Hoffman其他文献

Lauren A Hoffman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lauren A Hoffman', 18)}}的其他基金

Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers
开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验
  • 批准号:
    10590626
  • 财政年份:
    2022
  • 资助金额:
    $ 18.52万
  • 项目类别:
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients [SUPPLEMENT]
阿片类药物使用障碍、认知和恢复:丁丙诺啡和美沙酮治疗患者的神经心理变化和相关恢复结果的调查[补充]
  • 批准号:
    10405308
  • 财政年份:
    2022
  • 资助金额:
    $ 18.52万
  • 项目类别:
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients
阿片类药物使用障碍、认知和恢复:丁丙诺啡和美沙酮治疗患者神经心理变化和相关恢复结果的调查
  • 批准号:
    10092146
  • 财政年份:
    2019
  • 资助金额:
    $ 18.52万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了